Optimize, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Privately held developer of eyeglass-mounted imaging systems will ramp up sales and marketing initiatives for its FDA-cleared OptiVu HDVD minimally invasive surgical display system following the completion of a $14 mil. round of financing. The system will be introduced at the Oct. 22-27 Annual Clinical Congress of the American College of Surgeons in Chicago. The device consists of a wireless headset, a videoscopic camera, a base station to receive signals from the camera and convert them for infrared transmission, and an IR transceiver to send and receive the IR signal to and from the headset. The headset "produces an apparent, full-color endoscopic image directly in the line of sight of surgeons," the firm explains. "We exceeded our targeted investment, reflecting the excitement about our technology and product," said CEO Jim Pfeiffer. Invesco Global Health Sciences Fund led new investors while contributing previous investors included St. Paul Venture Capital, Patricof & Co., and Crescendo Ventures
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.